<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32345615</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1943-2631</ISSN><JournalIssue CitedMedium="Internet"><Volume>215</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Genetics</Title><ISOAbbreviation>Genetics</ISOAbbreviation></Journal><ArticleTitle>Amyotrophic Lateral Sclerosis Modifiers in <i>Drosophila</i> Reveal the Phospholipase D Pathway as a Potential Therapeutic Target.</ArticleTitle><Pagination><StartPage>747</StartPage><EndPage>766</EndPage><MedlinePgn>747-766</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1534/genetics.119.302985</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease, is a devastating neurodegenerative disorder lacking effective treatments. ALS pathology is linked to mutations in &gt;20 different genes indicating a complex underlying genetic architecture that is effectively unknown. Here, in an attempt to identify genes and pathways for potential therapeutic intervention and explore the genetic circuitry underlying <i>Drosophila</i> models of ALS, we carry out two independent genome-wide screens for modifiers of degenerative phenotypes associated with the expression of transgenic constructs carrying familial ALS-causing alleles of FUS (hFUS<sup>R521C</sup>) and TDP-43 (hTDP-43<sup>M337V</sup>). We uncover a complex array of genes affecting either or both of the two strains, and investigate their activities in additional ALS models. Our studies indicate the pathway that governs phospholipase D activity as a major modifier of ALS-related phenotypes, a notion supported by data we generated in mice and others collected in humans.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 by the Genetics Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kankel</LastName><ForeName>Mark W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Neuromuscular and Movement Disorders Research Unit, Biogen, Cambridge, Massachusetts 02142.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sen</LastName><ForeName>Anindya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neuromuscular and Movement Disorders Research Unit, Biogen, Cambridge, Massachusetts 02142.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Center for Motor Neuron Biology and Disease, Columbia University, New York 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theodorou</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimlich</LastName><ForeName>Douglas N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCampbell</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neuromuscular and Movement Disorders Research Unit, Biogen, Cambridge, Massachusetts 02142.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henderson</LastName><ForeName>Christopher E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Neuromuscular and Movement Disorders Research Unit, Biogen, Cambridge, Massachusetts 02142.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shneider</LastName><ForeName>Neil A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Center for Motor Neuron Biology and Disease, Columbia University, New York 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Artavanis-Tsakonas</LastName><ForeName>Spyros</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9112-1518</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 artavanis@hms.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Genetics</MedlineTA><NlmUniqueID>0374636</NlmUniqueID><ISSNLinking>0016-6731</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.4.4</RegistryNumber><NameOfSubstance UI="D010739">Phospholipase D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060045" MajorTopicYN="Y">Genes, Modifier</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010739" MajorTopicYN="N">Phospholipase D</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019076" MajorTopicYN="N">Transgenes</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">C9ORF72</Keyword><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">TDP43</Keyword><Keyword MajorTopicYN="N">phospholipase D (PLD)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32345615</ArticleId><ArticleId IdType="pmc">PMC7337071</ArticleId><ArticleId IdType="doi">10.1534/genetics.119.302985</ArticleId><ArticleId IdType="pii">genetics.119.302985</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abe K., Aoki M., Tsuji S., Itoyama Y., Sobue G. et al. , 2017. &#x2003;Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 16: 505&#x2013;512. 10.1016/S1474-4422(17)30115-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammar M. R., Thahouly T., Hanauer A., Stegner D., Nieswandt B. et al. , 2015. &#x2003;PLD1 participates in BDNF-induced signalling in cortical neurons. Sci. Rep. 5: 14778 10.1038/srep14778</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep14778</ArticleId><ArticleId IdType="pmc">PMC4594037</ArticleId><ArticleId IdType="pubmed">26437780</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson M. K., Stahlberg A., Arvidsson Y., Olofsson A., Semb H. et al. , 2008. &#x2003;The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol. 9: 37 10.1186/1471-2121-9-37</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2121-9-37</ArticleId><ArticleId IdType="pmc">PMC2478660</ArticleId><ArticleId IdType="pubmed">18620564</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T. et al. , 2006. &#x2003;TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351: 602&#x2013;611. 10.1016/j.bbrc.2006.10.093</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Artavanis-Tsakonas S., 2004. &#x2003;Accessing the exelixis collection. Nat. Genet. 36: 207 10.1038/ng1316</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1316</ArticleId><ArticleId IdType="pubmed">14981522</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala Y. M., Zago P., D&#x2019;Ambrogio A., Xu Y. F., Petrucelli L. et al. , 2008. &#x2003;Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 121: 3778&#x2013;3785. 10.1242/jcs.038950</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.038950</ArticleId><ArticleId IdType="pubmed">18957508</ArticleId></ArticleIdList></Reference><Reference><Citation>Barclay Z., Dickson L., Robertson D., Johnson M., Holland P. et al. , 2013. &#x2003;Attenuated PLD1 association and signalling at the H452Y polymorphic form of the 5-HT(2A) receptor. Cell. Signal. 25: 814&#x2013;821. 10.1016/j.cellsig.2013.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2013.01.004</ArticleId><ArticleId IdType="pubmed">23314176</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Hur V., Denichenko P., Siegfried Z., Maimon A., Krainer A. et al. , 2013. &#x2003;S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1. Cell Rep. 3: 103&#x2013;115. 10.1016/j.celrep.2012.11.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.11.020</ArticleId><ArticleId IdType="pmc">PMC5021319</ArticleId><ArticleId IdType="pubmed">23273915</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischof J., Bjorklund M., Furger E., Schertel C., Taipale J. et al. , 2013. &#x2003;A versatile platform for creating a comprehensive UAS-ORFeome library in Drosophila. Development 140: 2434&#x2013;2442. 10.1242/dev.088757</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.088757</ArticleId><ArticleId IdType="pubmed">23637332</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodemann B. O., and White M. A., 2008. &#x2003;Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat. Rev. Cancer 8: 133&#x2013;140. 10.1038/nrc2296</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc2296</ArticleId><ArticleId IdType="pubmed">18219307</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandenburg L. O., Konrad M., Wruck C., Koch T., Pufe T. et al. , 2008. &#x2003;Involvement of formyl-peptide-receptor-like-1 and phospholipase D in the internalization and signal transduction of amyloid beta 1&#x2013;42 in glial cells. Neuroscience 156: 266&#x2013;276. 10.1016/j.neuroscience.2008.07.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2008.07.042</ArticleId><ArticleId IdType="pubmed">18723082</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R. H., and Al-Chalabi A., 2017. &#x2003;Amyotrophic lateral sclerosis. N. Engl. J. Med. 377: 162&#x2013;172. 10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruntz R. C., Lindsley C. W., and Brown H. A., 2014. &#x2003;Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer. Pharmacol. Rev. 66: 1033&#x2013;1079. 10.1124/pr.114.009217</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.114.009217</ArticleId><ArticleId IdType="pmc">PMC4180337</ArticleId><ArticleId IdType="pubmed">25244928</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunton-Stasyshyn R. K., Saccon R. A., Fratta P., and Fisher E. M., 2015. &#x2003;SOD1 function and its implications for amyotrophic lateral sclerosis pathology: new and renascent themes. Neuroscientist 21: 519&#x2013;529. 10.1177/1073858414561795</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858414561795</ArticleId><ArticleId IdType="pubmed">25492944</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., and Baralle F. E., 2001. &#x2003;Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 276: 36337&#x2013;36343. 10.1074/jbc.M104236200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M104236200</ArticleId><ArticleId IdType="pubmed">11470789</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S., Walsh C., Lynch C., Bede P., Elamin M. et al. , 2011. &#x2003;Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry 82: 623&#x2013;627. 10.1136/jnnp.2010.224501</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.224501</ArticleId><ArticleId IdType="pubmed">21047878</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#xe1;ceres J. F., and Krainer A. R., 1993. &#x2003;Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains. EMBO J. 12: 4715&#x2013;4726. 10.1002/j.1460-2075.1993.tb06160.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1993.tb06160.x</ArticleId><ArticleId IdType="pmc">PMC413916</ArticleId><ArticleId IdType="pubmed">8223480</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai D., Zhong M., Wang R., Netzer W. J., Shields D. et al. , 2006. &#x2003;Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer&#x2019;s disease-linked presenilin-1 mutant neurons. Proc. Natl. Acad. Sci. USA 103: 1936&#x2013;1940. 10.1073/pnas.0510710103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0510710103</ArticleId><ArticleId IdType="pmc">PMC1413666</ArticleId><ArticleId IdType="pubmed">16449385</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H. C., Dimlich D. N., Yokokura T., Mukherjee A., Kankel M. W. et al. , 2008. &#x2003;Modeling spinal muscular atrophy in Drosophila. PLoS One 3: e3209 10.1371/journal.pone.0003209</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0003209</ArticleId><ArticleId IdType="pmc">PMC2527655</ArticleId><ArticleId IdType="pubmed">18791638</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y. Z., Bennett C. L., Huynh H. M., Blair I. P., Puls I. et al. , 2004. &#x2003;DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet. 74: 1128&#x2013;1135. 10.1086/421054</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/421054</ArticleId><ArticleId IdType="pmc">PMC1182077</ArticleId><ArticleId IdType="pubmed">15106121</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q., Hongu T., Sato T., Zhang Y., Ali W. et al. , 2012. &#x2003;Key roles for the lipid signaling enzyme phospholipase d1 in the tumor microenvironment during tumor angiogenesis and metastasis. Sci. Signal. 5: ra79 10.1126/scisignal.2003257</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2003257</ArticleId><ArticleId IdType="pmc">PMC3721670</ArticleId><ArticleId IdType="pubmed">23131846</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Kankel M. W., Su S. C., Han S. W. S., and Ofengeim D., 2018. &#x2003;Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD. Cell Death Differ. 25: 648&#x2013;660. 10.1038/s41418-018-0060-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-018-0060-4</ArticleId><ArticleId IdType="pmc">PMC5864209</ArticleId><ArticleId IdType="pubmed">29459769</ArticleId></ArticleIdList></Reference><Reference><Citation>Chenna R., 2003. &#x2003;Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31: 3497&#x2013;3500. 10.1093/nar/gkg500</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkg500</ArticleId><ArticleId IdType="pmc">PMC168907</ArticleId><ArticleId IdType="pubmed">12824352</ArticleId></ArticleIdList></Reference><Reference><Citation>Choksi D. K., Roy B., Chatterjee S., Yusuff T., Bakhoum M. F. et al. , 2014. &#x2003;TDP-43 phosphorylation by casein kinase I&#x3b5; promotes oligomerization and enhances toxicity in vivo. Hum. Mol. Genet. 23: 1025&#x2013;1035. 10.1093/hmg/ddt498</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt498</ArticleId><ArticleId IdType="pubmed">24105464</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C. C., Zhang Y., Umoh M. E., Vaughan S. W., Lorenzini I. et al. , 2018. &#x2003;TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 21: 228&#x2013;239. 10.1038/s41593-017-0047-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung S. Y., Moriyama T., Uezu E., Uezu K., Hirata R. et al. , 1995. &#x2003;Administration of phosphatidylcholine increases brain acetylcholine concentration and improves memory in mice with dementia. J. Nutr. 125: 1484&#x2013;1489.</Citation><ArticleIdList><ArticleId IdType="pubmed">7782901</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A. N., Siddegowda B. B., Estes P. S., Johannesmeyer J., Kovalik T. et al. , 2014. &#x2003;Futsch/MAP1B mRNA is a translational target of TDP-43 and is neuroprotective in a Drosophila model of amyotrophic lateral sclerosis. J. Neurosci. 34: 15962&#x2013;15974. 10.1523/JNEUROSCI.2526-14.2014</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2526-14.2014</ArticleId><ArticleId IdType="pmc">PMC4244467</ArticleId><ArticleId IdType="pubmed">25429138</ArticleId></ArticleIdList></Reference><Reference><Citation>Crozat A., Aman P., Mandahl N., and Ron D., 1993. &#x2003;Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363: 640&#x2013;644. 10.1038/363640a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/363640a0</ArticleId><ArticleId IdType="pubmed">8510758</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigle J. G., Lanson N. A. Jr., Smith R. B., Casci I., Maltare A. et al. , 2013. &#x2003;RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. Hum. Mol. Genet. 22: 1193&#x2013;1205. 10.1093/hmg/dds526</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds526</ArticleId><ArticleId IdType="pmc">PMC3578413</ArticleId><ArticleId IdType="pubmed">23257289</ArticleId></ArticleIdList></Reference><Reference><Citation>Dall&#x2019;Armi C., Hurtado-Lorenzo A., Tian H., Morel E., Nezu A. et al. , 2010. &#x2003;The phospholipase D1 pathway modulates macroautophagy. Nat. Commun. 1: 142 10.1038/ncomms1144</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms1144</ArticleId><ArticleId IdType="pmc">PMC3328354</ArticleId><ArticleId IdType="pubmed">21266992</ArticleId></ArticleIdList></Reference><Reference><Citation>De Cuyper H., van Praag H. M., and Verstraeten D., 1984. &#x2003;The clinical significance of halopemide, a dopamine-blocker related to the butyrophenones. Neuropsychobiology 12: 211&#x2013;216. 10.1159/000118141</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000118141</ArticleId><ArticleId IdType="pubmed">6398861</ArticleId></ArticleIdList></Reference><Reference><Citation>Deacon R. M., 2013. &#x2003;Measuring the strength of mice. J. Vis. Exp. (76), e2610 10.3791/2610</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/2610</ArticleId><ArticleId IdType="pmc">PMC3725666</ArticleId><ArticleId IdType="pubmed">23770643</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H., Gao K., and Jankovic J., 2014. &#x2003;The role of FUS gene variants in neurodegenerative diseases. Nat. Rev. Neurol. 10: 337&#x2013;348. 10.1038/nrneurol.2014.78</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.78</ArticleId><ArticleId IdType="pubmed">24840975</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H., and Dormann D., 2017. &#x2003;TDP-43 and FUS en route from the nucleus to the cytoplasm. FEBS Lett. 591: 1489&#x2013;1507. 10.1002/1873-3468.12646</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12646</ArticleId><ArticleId IdType="pubmed">28380257</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes P. S., Boehringer A., Zwick R., Tang J. E., Grigsby B. et al. , 2011. &#x2003;Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum. Mol. Genet. 20: 2308&#x2013;2321. 10.1093/hmg/ddr124</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr124</ArticleId><ArticleId IdType="pmc">PMC3098735</ArticleId><ArticleId IdType="pubmed">21441568</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiguin F., Godena V. K., Romano G., D&#x2019;Ambrogio A., Klima R. et al. , 2009. &#x2003;Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett. 583: 1586&#x2013;1592. 10.1016/j.febslet.2009.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2009.04.019</ArticleId><ArticleId IdType="pubmed">19379745</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster D. A., and Xu L., 2003. &#x2003;Phospholipase D in cell proliferation and cancer. Mol. Cancer Res. 1: 789&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pubmed">14517341</ArticleId></ArticleIdList></Reference><Reference><Citation>Fregoso O. I., Das S., Akerman M., and Krainer A. R., 2013. &#x2003;Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence. Mol. Cell 50: 56&#x2013;66. 10.1016/j.molcel.2013.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.02.001</ArticleId><ArticleId IdType="pmc">PMC3628402</ArticleId><ArticleId IdType="pubmed">23478443</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B., Lu Y., Lopez-Gonzalez R., Kim N. C., Almeida S. et al. , 2015. &#x2003;GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525: 129&#x2013;133. 10.1038/nature14974</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujisawa T., Takahashi M., Tsukamoto Y., Yamaguchi N., Nakoji M. et al. , 2016. &#x2003;The ASK1-specific inhibitors K811 and K812 prolong survival in a mouse model of amyotrophic lateral sclerosis. Hum. Mol. Genet. 25: 245&#x2013;253. 10.1093/hmg/ddv467</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv467</ArticleId><ArticleId IdType="pubmed">26604152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M., and Brown R. H. Jr, 2018. &#x2003;Genetics of amyotrophic lateral sclerosis. Cold Spring Harb. Perspect. Med. 8: a024125. 10.1101/cshperspect.a024125</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024125</ArticleId><ArticleId IdType="pmc">PMC5932579</ArticleId><ArticleId IdType="pubmed">28270533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson S. B., Downie J. M., Tsetsou S., Feusier J. E., Figueroa K. P. et al. , 2017. &#x2003;The evolving genetic risk for sporadic ALS. Neurology 89: 226&#x2013;233. 10.1212/WNL.0000000000004109</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004109</ArticleId><ArticleId IdType="pmc">PMC5513819</ArticleId><ArticleId IdType="pubmed">28642336</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman L. D., and Bonini N. M., 2020. &#x2003;New roles for canonical transcription factors in repeat expansion diseases. Trends Genet. 36: 81&#x2013;92. 10.1016/j.tig.2019.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2019.11.003</ArticleId><ArticleId IdType="pmc">PMC6980727</ArticleId><ArticleId IdType="pubmed">31837826</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros-Louis F., Gaspar C., and Rouleau G. A., 2006. &#x2003;Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762: 956&#x2013;972. 10.1016/j.bbadis.2006.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.01.004</ArticleId><ArticleId IdType="pubmed">16503123</ArticleId></ArticleIdList></Reference><Reference><Citation>Guruharsha K. G., Rual J. F., Zhai B., Mintseris J., Vaidya P. et al. , 2011. &#x2003;A protein complex network of Drosophila melanogaster. Cell 147: 690&#x2013;703. 10.1016/j.cell.2011.08.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.08.047</ArticleId><ArticleId IdType="pmc">PMC3319048</ArticleId><ArticleId IdType="pubmed">22036573</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., and van den Berg L. H., 2017. &#x2003;Edaravone- a new treatment for ALS on the horizon? Lancet Neurol. 16: 490&#x2013;491. 10.1016/S1474-4422(17)30163-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30163-1</ArticleId><ArticleId IdType="pubmed">28522180</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M., Nonaka T., and Masuda-Suzukake M., 2017. &#x2003;Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders. Pharmacol. Ther. 172: 22&#x2013;33. 10.1016/j.pharmthera.2016.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2016.11.010</ArticleId><ArticleId IdType="pubmed">27916654</ArticleId></ArticleIdList></Reference><Reference><Citation>Hautbergue G. M., Castelli L. M., Ferraiuolo L., Sanchez-Martinez A., Cooper-Knock J. et al. , 2017. &#x2003;SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits. Nat. Commun. 8: 16063 10.1038/ncomms16063</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms16063</ArticleId><ArticleId IdType="pmc">PMC5504286</ArticleId><ArticleId IdType="pubmed">28677678</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A., Pitzer C., and Schneider A., 2010. &#x2003;Characterization of a novel SOD-1(G93A) transgenic mouse line with very decelerated disease development. PLoS One 5: e15445 10.1371/journal.pone.0015445</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015445</ArticleId><ArticleId IdType="pmc">PMC2978730</ArticleId><ArticleId IdType="pubmed">21102999</ArticleId></ArticleIdList></Reference><Reference><Citation>Hori K., Sen A., Kirchhausen T., and Artavanis-Tsakonas S., 2011. &#x2003;Synergy between the ESCRT-III complex and Deltex defines a ligand-independent Notch signal. J. Cell Biol. 195: 1005&#x2013;1015. 10.1083/jcb.201104146</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201104146</ArticleId><ArticleId IdType="pmc">PMC3241730</ArticleId><ArticleId IdType="pubmed">22162134</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Dey S., Zhang X., Sonnichsen F., and Garner P., 2004. &#x2003;The alpha-helical peptide nucleic acid concept: merger of peptide secondary structure and codified nucleic acid recognition. J. Am. Chem. Soc. 126: 4626&#x2013;4640. 10.1021/ja038434s</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja038434s</ArticleId><ArticleId IdType="pubmed">15070379</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Flockhart I., Vinayagam A., Bergwitz C., Berger B. et al. , 2011. &#x2003;An integrative approach to ortholog prediction for disease-focused and other functional studies. BMC Bioinformatics 12: 357 10.1186/1471-2105-12-357</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-12-357</ArticleId><ArticleId IdType="pmc">PMC3179972</ArticleId><ArticleId IdType="pubmed">21880147</ArticleId></ArticleIdList></Reference><Reference><Citation>Iko Y., Kodama T. S., Kasai N., Oyama T., Morita E. H. et al. , 2004. &#x2003;Domain architectures and characterization of an RNA-binding protein, TLS. J. Biol. Chem. 279: 44834&#x2013;44840. 10.1074/jbc.M408552200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M408552200</ArticleId><ArticleId IdType="pubmed">15299008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D., Hatano M., and Suzuki N., 2017. &#x2003;RNA binding proteins and the pathological cascade in ALS/FTD neurodegeneration. Sci. Transl. Med. 9: eaah5436. 10.1126/scitranslmed.aah5436</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aah5436</ArticleId><ArticleId IdType="pubmed">29118263</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;ci&#x107; A., Mertens J., Boeynaems S., Bogaert E., Chai N. et al. , 2015. &#x2003;Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat. Neurosci. 18: 1226&#x2013;1229. 10.1038/nn.4085</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Kankel M. W., Duncan D. M., and Duncan I., 2004. &#x2003;A screen for genes that interact with the Drosophila pair-rule segmentation gene fushi tarazu. Genetics 168: 161&#x2013;180. 10.1534/genetics.104.027250</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.104.027250</ArticleId><ArticleId IdType="pmc">PMC1448101</ArticleId><ArticleId IdType="pubmed">15454535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kankel M. W., Hurlbut G. D., Upadhyay G., Yajnik V., Yedvobnick B. et al. , 2007. &#x2003;Investigating the genetic circuitry of mastermind in Drosophila, a notch signal effector. Genetics 177: 2493&#x2013;2505. 10.1534/genetics.107.080994</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.107.080994</ArticleId><ArticleId IdType="pmc">PMC2219471</ArticleId><ArticleId IdType="pubmed">18073442</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan A., Spiller K. J., Towne C., Kanning K. C., Choe G. T. et al. , 2014. &#x2003;Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron 81: 333&#x2013;348. 10.1016/j.neuron.2013.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.009</ArticleId><ArticleId IdType="pmc">PMC6015650</ArticleId><ArticleId IdType="pubmed">24462097</ArticleId></ArticleIdList></Reference><Reference><Citation>Karni R., Hippo Y., Lowe S. W., and Krainer A. R., 2008. &#x2003;The splicing-factor oncoprotein SF2/ASF activates mTORC1. Proc. Natl. Acad. Sci. USA 105: 15323&#x2013;15327. 10.1073/pnas.0801376105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0801376105</ArticleId><ArticleId IdType="pmc">PMC2563124</ArticleId><ArticleId IdType="pubmed">18832178</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M., Han T. W., Xie S., Shi K., Du X. et al. , 2012. &#x2003;Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell 149: 753&#x2013;767. 10.1016/j.cell.2012.04.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.04.017</ArticleId><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>King O. D., Gitler A. D., and Shorter J., 2012. &#x2003;The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 1462: 61&#x2013;80. 10.1016/j.brainres.2012.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.01.016</ArticleId><ArticleId IdType="pmc">PMC3372647</ArticleId><ArticleId IdType="pubmed">22445064</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo Y., Ren S., Lao U., Edgar B. A., and Wang T., 2013. &#x2003;Suppression of polyglutamine protein toxicity by co-expression of a heat-shock protein 40 and a heat-shock protein 110. Cell Death Dis. 4: e833 10.1038/cddis.2013.351</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.351</ArticleId><ArticleId IdType="pmc">PMC3824661</ArticleId><ArticleId IdType="pubmed">24091676</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T. J. Jr., Bosco D. A., Leclerc A. L., Tamrazian E., Vanderburg C. R. et al. , 2009a&#x2003;Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323: 1205&#x2013;1208. 10.1126/science.1166066</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T. J. J., Bosco D. A., LeClerc A. L., Tamrazian E., Vanderburg C. R. et al. , 2009b&#x2003;Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic Lateral sclerosis. Science 323: 1205&#x2013;1208. 10.1126/science.1166066</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., and Cleveland D. W., 2010. &#x2003;TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 19: R46&#x2013;R64. 10.1093/hmg/ddq137</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq137</ArticleId><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanson N. A. Jr., Maltare A., King H., Smith R., Kim J. H. et al. , 2011. &#x2003;A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. Hum. Mol. Genet. 20: 2510&#x2013;2523. 10.1093/hmg/ddr150</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr150</ArticleId><ArticleId IdType="pmc">PMC4288133</ArticleId><ArticleId IdType="pubmed">21487023</ArticleId></ArticleIdList></Reference><Reference><Citation>Larkin M. A., Blackshields G., Brown N. P., Chenna R., McGettigan P. A. et al. , 2007. &#x2003;Clustal W and clustal X version 2.0. Bioinformatics 23: 2947&#x2013;2948. 10.1093/bioinformatics/btm404</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btm404</ArticleId><ArticleId IdType="pubmed">17846036</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K. H., Zhang P., Kim H. J., Mitrea D. M., Sarkar M. et al. , 2016. &#x2003;C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell 167: 774&#x2013;788.e17. 10.1016/j.cell.2016.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Ray P., Rao E. J., Shi C., Guo W. et al. , 2010. &#x2003;A Drosophila model for TDP-43 proteinopathy. Proc. Natl. Acad. Sci. USA 107: 3169&#x2013;3174. 10.1073/pnas.0913602107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0913602107</ArticleId><ArticleId IdType="pmc">PMC2840283</ArticleId><ArticleId IdType="pubmed">20133767</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y. R., King O. D., Shorter J., and Gitler A. D., 2013. &#x2003;Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 201: 361&#x2013;372. 10.1083/jcb.201302044</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201302044</ArticleId><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M. T., and Beal M. F., 2006. &#x2003;Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787&#x2013;795. 10.1038/nature05292</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05292</ArticleId><ArticleId IdType="pubmed">17051205</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M. J., Cheng C. W., and Shen C. K., 2011. &#x2003;Neuronal function and dysfunction of Drosophila dTDP. PLoS One 6: e20371 10.1371/journal.pone.0020371</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020371</ArticleId><ArticleId IdType="pmc">PMC3105987</ArticleId><ArticleId IdType="pubmed">21673800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S. C., Polymenidou M., and Cleveland D. W., 2013. &#x2003;Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79: 416&#x2013;438. 10.1016/j.neuron.2013.07.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhang Y. W., Wang X., Zhang H., You X. et al. , 2009. &#x2003;Intracellular trafficking of presenilin 1 is regulated by &#x3b2;-amyloid precursor protein and phospholipase D1. J. Biol. Chem. 284: 12145&#x2013;12152. 10.1074/jbc.M808497200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M808497200</ArticleId><ArticleId IdType="pmc">PMC2673283</ArticleId><ArticleId IdType="pubmed">19276086</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Zhou T., Ziegler A. C., Dimitrion P., and Zuo L., 2017. &#x2003;Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications. Oxid. Med. Cell. Longev. 2017: 2525967 10.1155/2017/2525967</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/2525967</ArticleId><ArticleId IdType="pmc">PMC5529664</ArticleId><ArticleId IdType="pubmed">28785371</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I. R., Rademakers R., and Neumann M., 2010. &#x2003;TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 9: 995&#x2013;1007. 10.1016/S1474-4422(10)70195-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70195-2</ArticleId><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Markmiller S., Soltanieh S., Server K. L., Mak R., Jin W. et al. , 2018. Context-dependent and disease-specific diversity in protein interactions within stress granules. Cell 172: 590&#x2013;604.e13. 10.1016/j.cell.2017.12.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.12.032</ArticleId><ArticleId IdType="pmc">PMC5969999</ArticleId><ArticleId IdType="pubmed">29373831</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Morino H., Ito H., Izumi Y., Kato H. et al. , 2010. &#x2003;Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465: 223&#x2013;226. 10.1038/nature08971</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L., Berson A., and Bonini N. M., 2015. &#x2003;Drosophila as an in vivo model for human neurodegenerative disease. Genetics 201: 377&#x2013;402. 10.1534/genetics.115.179457</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.115.179457</ArticleId><ArticleId IdType="pmc">PMC4596656</ArticleId><ArticleId IdType="pubmed">26447127</ArticleId></ArticleIdList></Reference><Reference><Citation>Michlewski G., Sanford J. R., and Caceres J. F., 2008. &#x2003;The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E&#x2013;BP1. Mol. Cell 30: 179&#x2013;189. 10.1016/j.molcel.2008.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2008.03.013</ArticleId><ArticleId IdType="pubmed">18439897</ArticleId></ArticleIdList></Reference><Reference><Citation>Miguel L., Frebourg T., Campion D., and Lecourtois M., 2011. &#x2003;Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies. Neurobiol. Dis. 41: 398&#x2013;406. 10.1016/j.nbd.2010.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.10.007</ArticleId><ArticleId IdType="pubmed">20951205</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi H., Muruganujan A., Casagrande J. T., and Thomas P. D., 2013. &#x2003;Large-scale gene function analysis with the PANTHER classification system. Nat. Protoc. 8: 1551&#x2013;1566. 10.1038/nprot.2013.092</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2013.092</ArticleId><ArticleId IdType="pmc">PMC6519453</ArticleId><ArticleId IdType="pubmed">23868073</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira M. C., Klur S., Watanabe M., Nemeth A. H., Le Ber I. et al. , 2004. &#x2003;Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat. Genet. 36: 225&#x2013;227. 10.1038/ng1303</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1303</ArticleId><ArticleId IdType="pubmed">14770181</ArticleId></ArticleIdList></Reference><Reference><Citation>Moujalled D., and White A. R., 2016. &#x2003;Advances in the development of disease-modifying treatments for amyotrophic lateral sclerosis. CNS Drugs 30: 227&#x2013;243. 10.1007/s40263-016-0317-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-016-0317-8</ArticleId><ArticleId IdType="pubmed">26895253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy M., Fenton W. A., Li D., Furtak K., and Horwich A. L., 2016. &#x2003;Extended survival of misfolded G85R SOD1-linked ALS mice by transgenic expression of chaperone Hsp110. Proc. Natl. Acad. Sci. USA 113: 5424&#x2013;5428. 10.1073/pnas.1604885113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1604885113</ArticleId><ArticleId IdType="pmc">PMC4868459</ArticleId><ArticleId IdType="pubmed">27114530</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D. M., Kwong L. K., Truax A. C., Micsenyi M. C. et al. , 2006. &#x2003;Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130&#x2013;133. 10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallavi S. K., Ho D. M., Hicks C., Miele L., and Artavanis-Tsakonas S., 2012. &#x2003;Notch and Mef2 synergize to promote proliferation and metastasis through JNK signal activation in Drosophila. EMBO J. 31: 2895&#x2013;2907. 10.1038/emboj.2012.129</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.129</ArticleId><ArticleId IdType="pmc">PMC3395089</ArticleId><ArticleId IdType="pubmed">22580825</ArticleId></ArticleIdList></Reference><Reference><Citation>Parks A. L., Cook K. R., Belvin M., Dompe N. A., Fawcett R. et al. , 2004. &#x2003;Systematic generation of high-resolution deletion coverage of the Drosophila melanogaster genome. Nat. Genet. 36: 288&#x2013;292. 10.1038/ng1312</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1312</ArticleId><ArticleId IdType="pubmed">14981519</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng X., and Frohman M. A., 2012. &#x2003;Mammalian phospholipase D physiological and pathological roles. Acta Physiol. (Oxf.) 204: 219&#x2013;226. 10.1111/j.1748-1716.2011.02298.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1748-1716.2011.02298.x</ArticleId><ArticleId IdType="pmc">PMC3137737</ArticleId><ArticleId IdType="pubmed">21447092</ArticleId></ArticleIdList></Reference><Reference><Citation>Periz G., Lu J., Zhang T., Kankel M. W., Jablonski A. M. et al. , 2015. &#x2003;Regulation of protein quality control by UBE4B and LSD1 through p53-mediated transcription. PLoS Biol. 13: e1002114 10.1371/journal.pbio.1002114</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002114</ArticleId><ArticleId IdType="pmc">PMC4383508</ArticleId><ArticleId IdType="pubmed">25837623</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad D. D., Ouchida M., Lee L., Rao V. N., and Reddy E. S., 1994. &#x2003;TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 9: 3717&#x2013;3729.</Citation><ArticleIdList><ArticleId IdType="pubmed">7970732</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin S. J., Kim J. M., Baughn M., Libby R. T., Kim Y. J. et al. , 2010. &#x2003;Sporadic ALS has compartment-specific aberrant exon splicing and altered cell-matrix adhesion biology. Hum. Mol. Genet. 19: 313&#x2013;328. 10.1093/hmg/ddp498</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp498</ArticleId><ArticleId IdType="pmc">PMC2796893</ArticleId><ArticleId IdType="pubmed">19864493</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghu P., Coessens E., Manifava M., Georgiev P., Pettitt T. et al. , 2009. &#x2003;Rhabdomere biogenesis in Drosophila photoreceptors is acutely sensitive to phosphatidic acid levels. J. Cell Biol. 185: 129&#x2013;145. 10.1083/jcb.200807027</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200807027</ArticleId><ArticleId IdType="pmc">PMC2700502</ArticleId><ArticleId IdType="pubmed">19349583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswami M., Taylor J. P., and Parker R., 2013. &#x2003;Altered ribostasis: RNA-protein granules in degenerative disorders. Cell 154: 727&#x2013;736. 10.1016/j.cell.2013.07.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.07.038</ArticleId><ArticleId IdType="pmc">PMC3811119</ArticleId><ArticleId IdType="pubmed">23953108</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Lam M., Wing Y., Yim L., Chu W. et al. , 2015. &#x2003;Beneficial effect of phosphatidylcholine supplementation in alleviation of hypomania and insomnia in a Chinese bipolar hypomanic boy and a possible explanation to the effect at the genetic level. Springerplus 4: 235 10.1186/s40064-015-1002-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40064-015-1002-y</ArticleId><ArticleId IdType="pmc">PMC4476977</ArticleId><ArticleId IdType="pubmed">26120503</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A. E., Majounie E., Waite A., Simon-Sanchez J., Rollinson S. et al. , 2011. &#x2003;A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72: 257&#x2013;268. 10.1016/j.neuron.2011.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A. E., Chio A., and Traynor B. J., 2014. &#x2003;State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 17: 17&#x2013;23. 10.1038/nn.3584</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Rickman O. J., Baple E. L., and Crosby A. H., 2019. &#x2003;Lipid metabolic pathways converge in motor neuron degenerative diseases. Brain 143: 1073&#x2013;1087. 10.1093/brain/awz382</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz382</ArticleId><ArticleId IdType="pmc">PMC7174042</ArticleId><ArticleId IdType="pubmed">31848577</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritson G. P., Custer S. K., Freibaum B. D., Guinto J. B., Geffel D. et al. , 2010. &#x2003;TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. J. Neurosci. 30: 7729&#x2013;7739. 10.1523/JNEUROSCI.5894-09.2010</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5894-09.2010</ArticleId><ArticleId IdType="pmc">PMC2890254</ArticleId><ArticleId IdType="pubmed">20519548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross C. A., and Poirier M. A., 2004. &#x2003;Protein aggregation and neurodegenerative disease. Nat. Med. 10: S10&#x2013;S17. 10.1038/nm1066</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1066</ArticleId><ArticleId IdType="pubmed">15272267</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J. D., 2009. &#x2003;Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol. 65: S3&#x2013;S9. 10.1002/ana.21543</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21543</ArticleId><ArticleId IdType="pubmed">19191304</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland L. P., 2001. &#x2003;How amyotrophic lateral sclerosis got its name the clinical-pathologic genius of Jean-Martin Charcot. Arch. Neurol. 58: 512&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">11255459</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanematsu F., Nishikimi A., Watanabe M., Hongu T., Tanaka Y. et al. , 2013. &#x2003;Phosphatidic acid-dependent recruitment and function of the Rac activator DOCK1 during dorsal ruffle formation. J. Biol. Chem. 288: 8092&#x2013;8100. 10.1074/jbc.M112.410423</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.410423</ArticleId><ArticleId IdType="pmc">PMC3605628</ArticleId><ArticleId IdType="pubmed">23362269</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanford J. R., Gray N. K., Beckmann K., and Caceres J. F., 2004. &#x2003;A novel role for shuttling SR proteins in mRNA translation. Genes Dev. 18: 755&#x2013;768. 10.1101/gad.286404</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.286404</ArticleId><ArticleId IdType="pmc">PMC387416</ArticleId><ArticleId IdType="pubmed">15082528</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T., Hongu T., Sakamoto M., Funakoshi Y., and Kanaho Y., 2013. &#x2003;Molecular mechanisms of N-formyl-methionyl-leucyl-phenylalanine-induced superoxide generation and degranulation in mouse neutrophils: phospholipase D is dispensable. Mol. Cell. Biol. 33: 136&#x2013;145. 10.1128/MCB.00869-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00869-12</ArticleId><ArticleId IdType="pmc">PMC3536298</ArticleId><ArticleId IdType="pubmed">23109426</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen A., Dimlich D. N., Guruharsha K. G., Kankel M. W., Hori K. et al. , 2013. &#x2003;Genetic circuitry of Survival motor neuron, the gene underlying spinal muscular atrophy. Proc. Natl. Acad. Sci. USA 110: E2371&#x2013;E2380. 10.1073/pnas.1301738110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1301738110</ArticleId><ArticleId IdType="pmc">PMC3696827</ArticleId><ArticleId IdType="pubmed">23757500</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Nagy M., Nic W., Tyagi N. K., Fenton W. A. et al. , 2013. &#x2003;Molecular chaperone Hsp110 rescues a vesicle transport defect produced by an ALS-associated mutant SOD1 protein in squid axoplasm. Proc. Natl. Acad. Sci. USA 110: 5428&#x2013;5433. 10.1073/pnas.1303279110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1303279110</ArticleId><ArticleId IdType="pmc">PMC3619309</ArticleId><ArticleId IdType="pubmed">23509252</ArticleId></ArticleIdList></Reference><Reference><Citation>Staats K. A., Van Helleputte L., Jones A. R., Bento-Abreu A., Van Hoecke A. et al. , 2013. &#x2003;Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice. Neurobiol. Dis. 60: 11&#x2013;17. 10.1016/j.nbd.2013.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.08.006</ArticleId><ArticleId IdType="pubmed">23969236</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegner D., Thielmann I., Kraft P., Frohman M. A., Stoll G. et al. , 2013. &#x2003;Pharmacological inhibition of phospholipase D protects mice from occlusive thrombus formation and ischemic stroke&#x2013;brief report. Arterioscler. Thromb. Vasc. Biol. 33: 2212&#x2013;2217. 10.1161/ATVBAHA.113.302030</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.113.302030</ArticleId><ArticleId IdType="pubmed">23868933</ArticleId></ArticleIdList></Reference><Reference><Citation>Su W., Yeku O., Olepu S., Genna A., Park J. S. et al. , 2009. &#x2003;5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol. Pharmacol. 75: 437&#x2013;446. 10.1124/mol.108.053298</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.108.053298</ArticleId><ArticleId IdType="pmc">PMC2684902</ArticleId><ArticleId IdType="pubmed">19064628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Diaz Z., Fang X., Hart M. P., Chesi A. et al. , 2011. &#x2003;Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol. 9: e1000614 10.1371/journal.pbio.1000614</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000614</ArticleId><ArticleId IdType="pmc">PMC3082519</ArticleId><ArticleId IdType="pubmed">21541367</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung J. Y., Lee S. Y., Min D. S., Eom T. Y., Ahn Y. S. et al. , 2001. &#x2003;Differential activation of phospholipases by mitogenic EGF and neurogenic PDGF in immortalized hippocampal stem cell lines. J. Neurochem. 78: 1044&#x2013;1053. 10.1046/j.1471-4159.2001.00491.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2001.00491.x</ArticleId><ArticleId IdType="pubmed">11553678</ArticleId></ArticleIdList></Reference><Reference><Citation>Taes I., Timmers M., Hersmus N., Bento-Abreu A., Van Den Bosch L. et al. , 2013. &#x2003;Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS. Hum. Mol. Genet. 22: 1783&#x2013;1790. 10.1093/hmg/ddt028</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt028</ArticleId><ArticleId IdType="pubmed">23364049</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan A. Y., and Manley J. L., 2009. &#x2003;The TET family of proteins: functions and roles in disease. J. Mol. Cell Biol. 1: 82&#x2013;92. 10.1093/jmcb/mjp025</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjp025</ArticleId><ArticleId IdType="pmc">PMC2905059</ArticleId><ArticleId IdType="pubmed">19783543</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanishima M., Takashima S., Honda A., Yasuda D., Tanikawa T. et al. , 2017. &#x2003;Identification of optineurin as an Interleukin-1 receptor-associated kinase 1-binding protein and its role in regulation of MyD88-dependent signaling. J Biol Chem. 292: 17250&#x2013;17257. 10.1074/jbc.M117.813899</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.813899</ArticleId><ArticleId IdType="pmc">PMC5655504</ArticleId><ArticleId IdType="pubmed">28882891</ArticleId></ArticleIdList></Reference><Reference><Citation>Tateishi T., Hokonohara T., Yamasaki R., Miura S., Kikuchi H. et al. , 2010. &#x2003;Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation. Acta Neuropathol. 119: 355&#x2013;364. 10.1007/s00401-009-0621-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0621-1</ArticleId><ArticleId IdType="pubmed">19967541</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibault S. T., Singer M. A., Miyazaki W. Y., Milash B., Dompe N. A. et al. , 2004. &#x2003;A complementary transposon tool kit for Drosophila melanogaster using P and piggyBac. Nat. Genet. 36: 283&#x2013;287. 10.1038/ng1314</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1314</ArticleId><ArticleId IdType="pubmed">14981521</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M. R., Hardiman O., Benatar M., Brooks B. R., Chio A. et al. , 2013. &#x2003;Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 12: 310&#x2013;322. 10.1016/S1474-4422(13)70036-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70036-X</ArticleId><ArticleId IdType="pmc">PMC4565161</ArticleId><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De Vos K. J., Nishimura A. L. et al. , 2009. &#x2003;Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323: 1208&#x2013;1211. 10.1126/science.1165942</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt A., Herholz D., Fiesel F. C., Kaur K., Muller D. et al. , 2010. &#x2003;TDP-43-mediated neuron loss in vivo requires RNA-binding activity. PLoS One 5: e12247 10.1371/journal.pone.0012247</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0012247</ArticleId><ArticleId IdType="pmc">PMC2923622</ArticleId><ArticleId IdType="pubmed">20806063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J. W., Brent J. R., Tomlinson A., Shneider N. A., and McCabe B. D., 2011. &#x2003;The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. J. Clin. Invest. 121: 4118&#x2013;4126. 10.1172/JCI57883</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI57883</ArticleId><ArticleId IdType="pmc">PMC3195475</ArticleId><ArticleId IdType="pubmed">21881207</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I., Bella S., Cairnsa N. J., Millera T. M., and Baloh R. H., 2009. &#x2003;TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA 106: 18809&#x2013;18814. 10.1073/pnas.0908767106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton M. J., Igaz L. M., Wong M. M., Kwong L. K., Trojanowski J. Q. et al. , 2008. &#x2003;Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 283: 13302&#x2013;13309. 10.1074/jbc.M800342200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M800342200</ArticleId><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia R., Liu Y., Yang L., Gal J., Zhu H. et al. , 2012. &#x2003;Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS. Mol. Neurodegener. 7: 10 10.1186/1750-1326-7-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-10</ArticleId><ArticleId IdType="pmc">PMC3325858</ArticleId><ArticleId IdType="pubmed">22443542</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y. F., Gendron T. F., Zhang Y. J., Lin W. L., D&#x2019;Alton S. et al. , 2010. &#x2003;Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J. Neurosci. 30: 10851&#x2013;10859. 10.1523/JNEUROSCI.1630-10.2010</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1630-10.2010</ArticleId><ArticleId IdType="pmc">PMC3056148</ArticleId><ArticleId IdType="pubmed">20702714</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Poidevin M., Li X., Li Y., Shu L. et al. , 2013. &#x2003;Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc. Natl. Acad. Sci. USA 110: 7778&#x2013;7783. 10.1073/pnas.1219643110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1219643110</ArticleId><ArticleId IdType="pmc">PMC3651485</ArticleId><ArticleId IdType="pubmed">23553836</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon M. S., Yon C., Park S. Y., Oh D. Y., Han A. H. et al. , 2005. &#x2003;Role of phospholipase D1 in neurite outgrowth of neural stem cells. Biochem. Biophys. Res. Commun. 329: 804&#x2013;811. 10.1016/j.bbrc.2005.02.087</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2005.02.087</ArticleId><ArticleId IdType="pubmed">15752728</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C., Wan K. H., Hammonds A. S., Stapleton M., Carlson J. W. et al. , 2011. &#x2003;Development of expression-ready constructs for generation of proteomic libraries. Methods Mol. Biol. 723: 257&#x2013;272. 10.1007/978-1-61779-043-0_17</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-61779-043-0_17</ArticleId><ArticleId IdType="pubmed">21370071</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuva-Aydemir Y., Almeida S., Krishnan G., Gendron T. F., and Gao F. B., 2019. &#x2003;Transcription elongation factor AFF2/FMR2 regulates expression of expanded GGGGCC repeat-containing C9ORF72 allele in ALS/FTD. Nat. Commun. 10: 5466 10.1038/s41467-019-13477-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13477-8</ArticleId><ArticleId IdType="pmc">PMC6884579</ArticleId><ArticleId IdType="pubmed">31784536</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., and Krainer A. R., 2004. &#x2003;Involvement of SR proteins in mRNA surveillance. Mol. Cell 16: 597&#x2013;607. 10.1016/j.molcel.2004.10.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2004.10.031</ArticleId><ArticleId IdType="pubmed">15546619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., and Frohman M. A., 2014. &#x2003;Cellular and physiological roles for phospholipase D1 in cancer. J. Biol. Chem. 289: 22567&#x2013;22574. 10.1074/jbc.R114.576876</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R114.576876</ArticleId><ArticleId IdType="pmc">PMC4132764</ArticleId><ArticleId IdType="pubmed">24990946</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Kwon S., Yamaguchi T., Cubizolles F., Rousseaux S. et al. , 2008. &#x2003;Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol. Cell. Biol. 28: 1688&#x2013;1701. 10.1128/MCB.01154-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01154-06</ArticleId><ArticleId IdType="pmc">PMC2258784</ArticleId><ArticleId IdType="pubmed">18180281</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Binari R., Zhou R., and Perrimon N., 2010. &#x2003;A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics 184: 1165&#x2013;1179. 10.1534/genetics.109.112516</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.109.112516</ArticleId><ArticleId IdType="pmc">PMC2865916</ArticleId><ArticleId IdType="pubmed">20100940</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Donnelly C. J., Haeusler A. R., Grima J. C., Machamer J. B. et al. , 2015. &#x2003;The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525: 56&#x2013;61. 10.1038/nature14973</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y. B., Kang K., Zhang Y., Qi C., Li G. et al. , 2012. &#x2003;PLD1 negatively regulates dendritic branching. J. Neurosci. 32: 7960&#x2013;7969. 10.1523/JNEUROSCI.5378-11.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5378-11.2012</ArticleId><ArticleId IdType="pmc">PMC6620958</ArticleId><ArticleId IdType="pubmed">22674271</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo P., and Manley J. L., 1993. &#x2003;Functional domains of the human splicing factor ASF/SF2. EMBO J. 12: 4727&#x2013;4737. 10.1002/j.1460-2075.1993.tb06161.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1993.tb06161.x</ArticleId><ArticleId IdType="pmc">PMC413918</ArticleId><ArticleId IdType="pubmed">8223481</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>